A61K 35/65
Amphibians
Official title: Amphibians, e.g. toads, frogs, salamanders or newts
A61K35/65 (Amphibians) appears on 18 US grants and 28 published applications in this corpus.
Search patents in A61K- Granted patents
- 18
- Published applications
- 28
- Assignees
- 19
- Inventors
- 60
- Latest grant
- 27 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 2 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 3 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 0 | 3 |
| 2023 | 2 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Decellularized biomaterial from non-mammalian tissue27 May 2025US 12,311,079 B2Nextgen Biologics, Inc.
- Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles31 Oct 2023US 11,801,268 B2Capricor, Inc.
- Decellularized biomaterial from non-mammalian tissue30 May 2023US 11,660,376 B2NeXtGen Biologies, Inc.
- Compounds supports hematopoietic stem cells and red blood cells25 May 2021US 11,013,704 B2Board of Regents, The University of Texas System
- Decellularized biomaterial from non-mammalian tissue14 Apr 2020US 10,617,790 B2ISE Professional Testing & Consulting Services, Inc.
- Method for extraction and preparation of curcumin19 Feb 2026US 2026/0048026 A1Shaanxi Undersun Biomedtech Co.,Ltd
- Decellularized biomaterial from non-mammalian tissue14 Aug 2025US 2025/0256009 A1Nextgen Biologics, Inc.
- Novel methods for decellularizing extracellular matrix1 May 2025US 2025/0134801 A1RegenX Science, Inc.
- Improved methods for decellularizing extracellular matrix (ecm) and preparing decellularized ecm gels and uses thereof1 May 2025US 2025/0134934 A1RegenX Science, Inc.
- Decellularized biomaterial from non-mammalian tissue28 Sep 2023US 2023/0302198 A1Nextgen Biologics, Inc.
Most cited
By later US patents
- Pharmaceutical for treating tumors and method for making it11US 4,882,421 AAlfacell Corporation · 1989
- Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract9US 6,726,935 B2Cheil Jedang Corporation · 2004
- Decellularized biomaterial from non-mammalian tissue4US 10,617,790 B2ISE Professional Testing & Consulting Services, Inc. · 2020
- Use of Lactobacillus plantarum composition for manufacturing anti-fatigue probiotic composition to improve exercise performance2US 10,188,685 B2National Taiwan Sport University · 2019
- Pharmaceutical for treating tumors and methods for making it2US 4,888,172 AAlfaceu Corporation · 1989